Irritable Bowel Syndrome

Top Story

7 recent FDA updates you may have missed

September 20, 2019
FDA NewsPerspective

FDA approves Ibsrela for IBS-C in adults

September 13, 2019
The FDA on Thursday approved Ibsrela, a 50 mg, twice-daily oral therapy for irritable bowel syndrome with constipation in adults. “Ibsrela has the potential to…
By the Numbers

5 recent highlights in IBS

September 6, 2019
Recently published studies have demonstrated new developments in diarrhea- and constipation-predominant irritable bowel syndrome, as well as peppermint oil as a…
In the Journals

Peppermint oil ‘should not be ignored’ for IBS

August 29, 2019
Although it did not meet stringent recommended endpoints dictated by the FDA and European Medicines Agency, small intestinal-release peppermint oil reduced abdominal…
More Headlines »

Ace the Case: A 37-Year-Old Woman With Abdominal Pain and Constipation

There is no commercial support for this activity.

This educational activity will utilize a case study to discuss the assessment and management of a 37-year-old female…
More »
GI Bookshelf

Question 20: A 58-Year-Old Female Underwent A Screening Colonoscopy That Showed A 2.5-Cm Flat Polyp In The Proximal Ascending Colon. I Tattooed The Area And Biopsied The Polyp, Which Was Initially Reported As Hyperplastic. What Should I Do?

From Curbside Consultation in Endoscopy: 49 Clinical Questions, Second Edition
More »
Meeting News

VIDEO: Diet low in short-chain carbs helps ease irritable bowel syndrome pain

November 9, 2018
More »